Afro-IP stands out as a leading resource for African intellectual property news and analysis. The blog delivers updates on IP law and policy across Africa and is recognised for its consistent quality and valuable contributions to the field.
Read more about World’s Best IP Blogs – Afro-IPAuthor: Gaurav Mishra
Gaurav Mishra is an intellectual property attorney, coffee entrepreneur, and passionate educator. As an Associate Partner at BananaIP Counsels, he specializes in patents, trademarks, copyrights, and designs, working with global tech and innovation-driven clients.
World’s Best IP Blogs: Patently-O
Patently-O is a top US intellectual property blog offering empirical analysis and updates on patent law developments. Founded by Dennis Crouch, it is widely regarded as an essential resource for legal professionals and students.
Read more about World’s Best IP Blogs: Patently-OWorld’s Best IP Blogs – IPWatchdog
This post explores IPWatchdog, a leading blog in the intellectual property domain managed by Gene Quinn. It highlights the blog’s analytical approach to patent law, its educational resources for inventors, and its reputation as a trusted source for IP news and commentary.
Read more about World’s Best IP Blogs – IPWatchdogWorld’s Best IP Blogs – IPKat
This article analyses IPKat, a prominent intellectual property blog, focusing on its history, editorial team, and impact within the IP field. The review also suggests enhancements for user experience while recognising the blog’s role in disseminating IP knowledge.
Read more about World’s Best IP Blogs – IPKatHow to get a Global Patent Protection?
Patents are territorial rights with no true global protection. This post examines the Paris Convention and PCT routes for securing patent rights in multiple countries, offering strategic guidance based on legal requirements and market considerations.
Read more about How to get a Global Patent Protection?Extension of Waiver for Pharma Patents until 2033 A.D.
The WTO has extended the waiver on pharmaceutical patent enforcement for least developed countries until 2033. This move ensures continued access to affordable generics from India and highlights the ongoing tension between patient access and patent rights.
Read more about Extension of Waiver for Pharma Patents until 2033 A.D.The times, they are a-changin’
This post analyses recent changes in patent rules in India and the United States, focusing on foreign priority claim procedures and electronic file sharing. It highlights the implications of these rules for patent applicants and the examination process.
Read more about The times, they are a-changin’DIPP Draft Patent Rules – Salient Features
The DIPP Draft Patent Rules introduce notable amendments to the Patents Rules, 2003, focusing on electronic communication, expedited examination, and revised timelines. The new rules seek to improve efficiency and clarity in Indian patent procedures.
Read more about DIPP Draft Patent Rules – Salient FeaturesGene Sequences and Patents: Australian High Court Narrows Scope
The Australian High Court has narrowed the eligibility of gene patents, particularly concerning isolated DNA sequences in the BRCA1 case. This analysis explores the legal reasoning, statutory interpretation, and global impact on biotechnology patent law, following similar US Supreme Court decisions.
Read more about Gene Sequences and Patents: Australian High Court Narrows ScopeMerck v. Glenmark – A Bitter Battle of Pills
The Delhi High Court restrained Glenmark from manufacturing and marketing generic versions of Merck’s patented antidiabetic drugs. This case underscores key principles of Indian patent law and the balance between patent rights and public interest.
Read more about Merck v. Glenmark – A Bitter Battle of Pills